Alpha Glucosidase Inhibitors Market Revenues, Future Growth and Outlook, 2017–2025

1
GLOBAL MARKET ESTIMATES RESEARCH
CONSULTANTS Ankita Roy, Treesha Banerjee and
Liza Dsouza from Global Market Estimates throw
the spotlight on the growing Alpha Glucosidase
Inhibitors Market. Alpha-Glucosidase Inhibitors
Market Insights The Global Alpha-Glucosidase
Inhibitors market is expected to grow at a
moderate CAGR during the forecast period. The
market is driven by growing prevalence of type 1
and type 2 diabetes in population over the
world. Rise in the geriatric population in
emerging economies in the Asia Pacific region is
likely to further boost the market for
Alpha-Glucosidase Inhibitors. The market for
Alpha-Glucosidase Inhibitors is expected to be
larger in areas with high carbohydrate
consumption. However, Alpha-Glucosidase
Inhibitors are used as a second line monotherapy
treatment or are used in combination with
first-line therapy drugs. This is therefore
expected to hinder the market growth up to a
certain extent.
Alpha Glucosidase Inhibitors Market Disease Type
Insights On the basis of disease type, the
Alpha-Glucosidase Inhibitors market can be
segmented into type-1 and type-2 diabetes. Use
of Alpha-Glucosidase Inhibitors is higher in the
treatment of type-2 diabetes and is therefore
projected to hold the higher market share in
terms of revenue. The Asia Pacific region is
likely to contribute to the market growth in the
segment significantly. Growing awareness about
diabetes drugs over the world is also expected to
fuel market growth.
2
GLOBAL MARKET ESTIMATES RESEARCH
CONSULTANTS Alpha-Glucosidase Inhibitors Market
Distribution Channel Insights The Global
Alpha-Glucosidase Inhibitors market is segmented
into Online Pharmacies, Retail Pharmacies, and
Hospital Pharmacies based on the distribution
channel. The hospital pharmacies segment is
projected to hold the larger market share in
terms of revenue, followed by the retail
pharmacies segment. The online pharmacies segment
is likely to grow at the highest CAGR during the
forecast period due to growing digitization and
retail activities online. Alpha-Glucosidase
Inhibitors Market Regional Insights The Asia
Pacific market for Alpha-Glucosidase Inhibitors
is projected to grow at the highest CAGR owing
to a demonstrated rise in geriatric population
over the past few years along with a rise in
cases of type-2 diabetes. Rising disposable
income of individuals and awareness about
diabetes drugs in the region is also projected to
have a positive impact on the market. The North
American region is likely to hold the larger
market share in the Alpha-Glucosidase Inhibitors
Market owing to technological advancements and
easy availability of the drug in medical
facilities. The market for Alpha-Glucosidase
Inhibitors in Central South America is also
expected to grow at a significant rate due to
initiatives were taken by the Government to use
advanced drugs for diabetes treatment.
Alpha Glucosidase Inhibitors Market End-Use
Landscape The end-use landscape entails a list
of current and prospective consumers prevailing
across the regions. This section provides
company addresses, contact details, products, and
regional presence of companies who are
purchasing or are likely to purchase controlled
release fertilizer over the coming years. Some
leading consumers of controlled release
fertilizer are Cipla, and Apollo Hospitals among
others.
3

• GLOBAL MARKET ESTIMATES RESEARCH CONSULTANTS
• Alpha Glucosidase Inhibitors Market Vendor
  Landscape
• The report contains a chapter dedicated to
  vendors operating in the market, covering raw
  material manufactures, equipment developers,
  manufacturers, and distributors. The report
  provides these insights on a regional level. This
  section of the report entails contact details,
  experience, products manufactured/supplied, and
  geographical presence of companies.
• Alpha Glucosidase Inhibitors Market Share
  Competitor Analysis
• Some of the key players operating in the Alpha
  Glucosidase Inhibitors market are Bayer, Takeda,
  Pfizer, Glenmark pharma, Sun pharma, Torrent,
  Unichem, and Hexalag among others.
• The report segments the Alpha Glucosidase
  Inhibitors Market on the basis of By Disease
  Type
• Type 1
• Type 2
• Others
• By Distribution Channel
• Online Pharmacies
• Retail Pharmacies

4
GLOBAL MARKET ESTIMATES RESEARCH CONSULTANTS
This article contains text from the Alpha
Glucosidase Inhibitors Market Forecast to 2025
report For more information or to buy the report,
please visit https//www.globalmarketestimates.
com/alpha-glucosidase-inhibitors-market/
Check our annual research partnership service
at https//www.globalmarketestimates.com/annual-
research-partnership-services/